Deep Medicine Acquisition Corp. (DMAQ) Stock Analysis

What Deep Medicine Acquisition Corp. does

Deep Medicine Acquisition Corp. (DMAQ) currently operates as a non-operating entity, possessing no substantial business functions of its own. Its express purpose is to execute a business combination, which could entail a merger, an acquisition of equity or assets, or a reorganization, with one or more target companies. The firm's strategic efforts are specifically concentrated on identifying promising enterprises within the healthcare industry. Incorporated in 2020, DMAQ maintains its principal place of business in New York, New York.

Key metrics

ETFs linked to DMAQ

Broad-market and Financial Services sector ETFs an investor holding Deep Medicine Acquisition Corp. is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how DMAQ fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Frequently asked questions

What is the ticker symbol for Deep Medicine Acquisition Corp.?

Deep Medicine Acquisition Corp. trades under the ticker DMAQ on NASDAQ.

Which exchange is DMAQ listed on?

DMAQ is listed on NASDAQ.

What sector does Deep Medicine Acquisition Corp. operate in?

Deep Medicine Acquisition Corp. is classified in the Financial Services sector (Shell Companies industry).

How can PortView help analyze DMAQ in a portfolio?

PortView shows DMAQ's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.